Eli Lilly stock soars on positive weight-loss pill results
00:00 Brad Smith Eli Lilly shares surging after announcing positive results for its GLP-1 pill in its phase three clinical trial. The pill would offer an alternative to popular weight loss injections like Ozempic. Our very own, Anjali Khemlani, joins us …